C12Y 603/02019
Ubiquitin-protein ligase , i.e. ubiquitin-conjugating enzyme
Official title: Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme
C12Y603/02019 (Ubiquitin-protein ligase , i.e. ubiquitin-conjugating enzyme) appears on 108 US grants and 211 published applications in this corpus.
Search patents in C12Y- Granted patents
- 108
- Published applications
- 211
- Assignees
- 98
- Inventors
- 340
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 4 |
| 2004 | 0 | 5 |
| 2005 | 0 | 2 |
| 2006 | 1 | 7 |
| 2007 | 4 | 3 |
| 2008 | 3 | 5 |
| 2009 | 1 | 4 |
| 2010 | 0 | 4 |
| 2011 | 3 | 1 |
| 2012 | 1 | 8 |
| 2013 | 3 | 8 |
| 2014 | 4 | 43 |
| 2015 | 18 | 19 |
| 2016 | 14 | 16 |
| 2017 | 12 | 12 |
| 2018 | 7 | 14 |
| 2019 | 8 | 10 |
| 2020 | 8 | 10 |
| 2021 | 1 | 6 |
| 2022 | 6 | 6 |
| 2023 | 3 | 6 |
| 2024 | 0 | 6 |
| 2025 | 3 | 7 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified UBE3A gene for a gene therapy approach for Angelman syndrome15 Sep 2026US 12,734,250 B2University of South Florida
- Increasing Atoh1 life to drive sensorineural hair cell differentiation5 May 2026US 12,618,070 B2Massachusetts Eye and Ear Infirmary
- Methods of detecting UBE3A protein11 Nov 2025US 12,467,929 B2Biogen MA Inc.
- Protein expression strains29 Jul 2025US 12,371,457 B2Sartorius Albumedix Limited
- Methods and combinations for treatment and T cell modulation1 Apr 2025US 12,263,190 B2Juno Therapeutics, Inc.
- Programmable dna proteolysis target chimeras and methods of their use30 Jul 2026US 2026/0216229 A1Arizona Board of Regents on behalf of Arizona State University
- Treatment and prevention of disease mediated by wwp216 Jul 2026US 2026/0201389 A1National University of Singapore
- Method for culativating huanglongbing-resistant plant and application thereof2 Jul 2026US 2026/0185118 A1Institute of Microbiology, Chinese Academy of Sciences
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Bifunctional fusion proteins for ubiquitin-mediated degradation25 Sep 2025US 2025/0297240 A1Axelyf Ehf.
Most cited
By later US patents
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding basic helix-loop-helix family member E41125US 9,107,886 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1124US 9,095,552 B2Moderna Therapeutics, Inc. · 2015